204 related articles for article (PubMed ID: 29330750)
1. Immunologic and gene expression profiles of spontaneous canine oligodendrogliomas.
Filley A; Henriquez M; Bhowmik T; Tewari BN; Rao X; Wan J; Miller MA; Liu Y; Bentley RT; Dey M
J Neurooncol; 2018 May; 137(3):469-479. PubMed ID: 29330750
[TBL] [Abstract][Full Text] [Related]
2. Human Flt3L generates dendritic cells from canine peripheral blood precursors: implications for a dog glioma clinical trial.
Xiong W; Candolfi M; Liu C; Muhammad AK; Yagiz K; Puntel M; Moore PF; Avalos J; Young JD; Khan D; Donelson R; Pluhar GE; Ohlfest JR; Wawrowsky K; Lowenstein PR; Castro MG
PLoS One; 2010 Jun; 5(6):e11074. PubMed ID: 20552015
[TBL] [Abstract][Full Text] [Related]
3. Expression of Oligodendrocyte Precursor Cell Markers in Canine Oligodendrogliomas.
Kishimoto TE; Uchida K; Thongtharb A; Shibato T; Chambers JK; Nibe K; Kagawa Y; Nakayama H
Vet Pathol; 2018 Sep; 55(5):634-644. PubMed ID: 29852819
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Inflammatory Changes Associated with Canine Oligodendroglioma.
Sloma EA; Creneti CT; Erb HN; Miller AD
J Comp Pathol; 2015; 153(2-3):92-100. PubMed ID: 26145723
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical study of neural stem cell lineage markers in canine brains, gliomas, and a glioma cell line.
Yoshida K; Chambers JK; Uchida K
Vet Pathol; 2023 Jan; 60(1):35-46. PubMed ID: 36384382
[TBL] [Abstract][Full Text] [Related]
6. MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints.
Wei J; Nduom EK; Kong LY; Hashimoto Y; Xu S; Gabrusiewicz K; Ling X; Huang N; Qiao W; Zhou S; Ivan C; Fuller GN; Gilbert MR; Overwijk W; Calin GA; Heimberger AB
Neuro Oncol; 2016 May; 18(5):639-48. PubMed ID: 26658052
[TBL] [Abstract][Full Text] [Related]
7. Cerebral high-grade oligodendroglioma with sarcomatous transdifferentiation ("oligosarcoma") in a boxer dog.
Fadda A; Vajtai I; Lang J; Henke D; Oevermann A
J Vet Intern Med; 2014; 28(6):1881-5. PubMed ID: 25410956
[No Abstract] [Full Text] [Related]
8. Expression of vascular endothelial growth factor in tumors and plasma from dogs with primary intracranial neoplasms.
Rossmeisl JH; Duncan RB; Huckle WR; Troy GC
Am J Vet Res; 2007 Nov; 68(11):1239-45. PubMed ID: 17975980
[TBL] [Abstract][Full Text] [Related]
9. Epidermal Growth Factor Receptor and Ki-67 Expression in Canine Gliomas.
Fraser AR; Bacci B; le Chevoir MA; Long SN
Vet Pathol; 2016 Nov; 53(6):1131-1137. PubMed ID: 27154542
[TBL] [Abstract][Full Text] [Related]
10. Presence of neural progenitors in spontaneous canine gliomas: A histopathological and immunohistochemical study of 20 cases.
Fernández F; Deviers A; Dally C; Mogicato G; Delverdier M; Cauzinille L; Gnirs K; Añor S; de la Fuente C; Fondevila D; Pumarola M
Vet J; 2016 Mar; 209():125-32. PubMed ID: 26831167
[TBL] [Abstract][Full Text] [Related]
11. Expression of FOXP3 in Canine Gliomas: Immunohistochemical Study of Tumor-Infiltrating Regulatory Lymphocytes.
Pi Castro D; José-López R; Fernández Flores F; Rabanal Prados RM; Mandara MT; Arús C; Pumarola Batlle M
J Neuropathol Exp Neurol; 2020 Feb; 79(2):184-193. PubMed ID: 31846038
[TBL] [Abstract][Full Text] [Related]
12. Molecular signalling pathways in canine gliomas.
Boudreau CE; York D; Higgins RJ; LeCouteur RA; Dickinson PJ
Vet Comp Oncol; 2017 Mar; 15(1):133-150. PubMed ID: 25808605
[TBL] [Abstract][Full Text] [Related]
13. Microarray analysis of differentially expressed genes of primary tumors in the canine central nervous system.
Thomson SA; Kennerly E; Olby N; Mickelson JR; Hoffmann DE; Dickinson PJ; Gibson G; Breen M
Vet Pathol; 2005 Sep; 42(5):550-8. PubMed ID: 16145201
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging features of intracranial astrocytomas and oligodendrogliomas in dogs.
Young BD; Levine JM; Porter BF; Chen-Allen AV; Rossmeisl JH; Platt SR; Kent M; Fosgate GT; Schatzberg SJ
Vet Radiol Ultrasound; 2011; 52(2):132-41. PubMed ID: 21388463
[TBL] [Abstract][Full Text] [Related]
15. Inter-pathologist agreement on diagnosis, classification and grading of canine glioma.
Krane GA; Shockley KR; Malarkey DE; Miller AD; Miller CR; Tokarz DA; Jensen HL; Janardhan KS; Breen M; Mariani CL
Vet Comp Oncol; 2022 Dec; 20(4):881-889. PubMed ID: 35856268
[TBL] [Abstract][Full Text] [Related]
16. Oligodendroglioma with Neuronal Differentiation in Two Boxer Dogs.
Cornax I; Pluhar GE; Clark HB; O'Sullivan MG
J Comp Pathol; 2019 Oct; 172():11-16. PubMed ID: 31690408
[TBL] [Abstract][Full Text] [Related]
17. Optimization of adenoviral vector-mediated transgene expression in the canine brain in vivo, and in canine glioma cells in vitro.
Candolfi M; Pluhar GE; Kroeger K; Puntel M; Curtin J; Barcia C; Muhammad AK; Xiong W; Liu C; Mondkar S; Kuoy W; Kang T; McNeil EA; Freese AB; Ohlfest JR; Moore P; Palmer D; Ng P; Young JD; Lowenstein PR; Castro MG
Neuro Oncol; 2007 Jul; 9(3):245-58. PubMed ID: 17522335
[TBL] [Abstract][Full Text] [Related]
18. Anaplastic oligodendroglioma with leptomeningeal dissemination in a french bulldog.
Nakamoto Y; Fukunaga D; Uchida K; Mori T; Kishimoto T; Ozawa T
J Vet Med Sci; 2018 Nov; 80(10):1590-1595. PubMed ID: 30185721
[TBL] [Abstract][Full Text] [Related]
19. Naturally Occurring Canine Glioma as a Model for Novel Therapeutics.
Hubbard ME; Arnold S; Bin Zahid A; McPheeters M; Gerard O'Sullivan M; Tabaran AF; Hunt MA; Pluhar GE
Cancer Invest; 2018; 36(8):415-423. PubMed ID: 30234401
[TBL] [Abstract][Full Text] [Related]
20. Simultaneously occurring oligodendroglioma and meningioma in a dog.
Stacy BA; Stevenson TL; Lipsitz D; Higgins RJ
J Vet Intern Med; 2003; 17(3):357-9. PubMed ID: 12774980
[No Abstract] [Full Text] [Related]
[Next] [New Search]
